DBMR - Healthcare IT

Global PDX Models Market– Industry Trends and Forecast to 2025

  • Healthcare IT
  • Published Report
  • Jul 2018
  • Global
  • 200 Pages
  • No of Tables: 55
  • No of Figures: 147

Global PDX Models Market, By Type (Mice Models, Rat Models), Tumor Type (Respiratory Tumor Models, Urological Tumor Models, Gastrointestinal Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Others), Application (Preclinical Drug Development & Oncology Research, Biomarker Analysis), End User (Contract Research Organization, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)- Industry Trends and Forecast to 2025

Global PDX Models Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Global PDX models marketProminent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization. However, due to high cost of PDX models and strict regulations with respect to the utilization of animal models in cancer research are hindering the market growth.

Market Segmentation: Global PDX Models Market

  • The global PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.
  • The global PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
  • The global PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
  • The global PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
  • Based on geography, the market is segmented into 5 geographical regions

    •  North America
    • Europe
    • Asia-Pacific
    • South America and
    • Middle East & Africa

Key Drivers: Global PDX Models Market

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

Key Points: Global PDX Models Market

Charles River is going to dominate the PDX models market following with Crown Bioscience Inc., Champion Oncology, Inc., The Jackson Laboratory, Oncodesign, Wuxi Apptec, Horizon Discovery Group plc, Pharma test Services Ltd, Aragen Bioscience (Subsidiary of GVK Biosciences Private Limited), MI Bioresearch Inc., EUROPDX, Creative Animodel, Urolead, Xentech, Hera BioLabs and EPO BERLIN-BUCH GMBH among others.

  • The mice models segment is dominating the global PDX models market.
  • Respiratory tumor models segment is expected to grow with the highest CAGR of 15.3% in the forecast period 2018 to 2025.

SKU-

TABLE OF CONTENTS GLOBAL PDX MODELS MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL PDX MODELS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 SECONDARY SOURCES
2.8 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING NUMBER OF PHARMACEUTICAL R&D ACTIVITIES IN CANCER RESEARCH
3.1.2 PDX MODELS OFFER ADVANTAGES AS COMPARED WITH THE CLASSIC APPROACH
3.1.3 RISING NEED FOR PERSONALIZED MEDICINE
3.1.4 INCREASING SUPPORT FOR CANCER RESEARCH ACTIVITIES FROM GOVERNMENT AND NON-GOVERNMENT ORGANIZATION

3.2 RESTRAINTS

3.2.1 HIGH COST OF PDX MODELS
3.2.2 STRICT REGULATION WITH RESPECT TO THE UTILIZATION OF ANIMAL MODELS IN CANCER RESEARCH

3.3 OPPRTUNITIES

3.3.1 INCREASING DEMAND FOR HUMANIZED PDX MODELS

3.4 CHALLENGES

3.4.1 LIMITATIONS OF PDX MODELS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL PDX MODELS MARKET, BY TYPE

6.1 OVERVIEW
6.2 MICE MODELS
6.3 RAT MODELS

7 GLOBAL PDX MODELS MARKET, BY TUMOR TYPE

7.1 OVERVIEW
7.2 GASTROINTESTINAL TUMOR MODELS
7.3 GYNECOLOGICAL TUMOR MODELS
7.4 RESPIRATORY TUMOR MODELS
7.5 UROLOGICAL TUMOR MODELS
7.6 HEMATOLOGICAL TUMOR MODELS
7.7 OTHERS

8 GLOBAL PDX MODELS MARKET, BY APPLICATION

8.1 OVERVIEW
8.2 PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH
8.3 BIOMARKER ANALYSIS

9 GLOBAL PDX MODELS MARKET, BY END USER

9.1 OVERVIEW
9.2 CONTRACT RESEARCH ORGANIZATIONS
9.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.4 ACADEMIC AND RESEARCH INSTITUTIONS

10 GLOBAL PDX MODELS MARKET, BY GEOGRAPHY

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO

10.3 EUROPE

10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 SWITZERLAND
10.3.7 NETHERLANDS
10.3.8 TURKEY
10.3.9 BELGIUM
10.3.10 RUSSIA
10.3.11 REST OF EUROPE

10.4 ASIA PACIFIC

10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 SINGAPORE
10.4.7 THAILAND
10.4.8 MALAYSIA
10.4.9 INDONESIA
10.4.10 PHILIPPINES
10.4.11 REST OF ASIA PACIFIC

10.5 SOUTH AMERICA

10.5.1 BRAZIL
10.5.2 REST OF SOUTH AMERICA

10.6 MIDDLE EAST AND AFRICA

10.6.1 SOUTH AFRICA
10.6.2 REST OF MIDDLE EAST AND AFRICA

11 GLOBAL PDX MODELS MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC

12 COMPANY PROFILES

12.1 CHARLES RIVER

12.1.1 COMPANY OVERVIEW
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS

12.2 CROWN BIOSCIENCE INC. (SUBSIDIARY OF JSR CORPORATION)

12.2.1 COMPANY OVERVIEW
12.2.2 GEOGRAPHIC PRESENCE
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS

12.3 CHAMPION ONCOLOGY, INC

12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS

12.4 ARAGEN BIOSCIENCE (SUBSIDIARY OF GVK BIOSCIENCES PRIVATE LIMITED)

12.4.1 COMPANY OVERVIEW
12.4.2 PRODUCT PORTFOLIO
12.4.3 RECENT DEVELOPMENTS

12.5 CREATIVE ANIMODEL

12.5.1 COMPANY OVERVIEW
12.5.2 PRODUCT PORTFOLIO
12.5.3 RECENT DEVELOPMENTS

12.6 EPO BERLIN-BUCH GMBH

12.6.1 COMPANY OVERVIEW
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS

12.7 EUROPDX

12.7.1 COMPANY OVERVIEW
12.7.2 GEOGRAPHICAL PRESENCE
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENTS

12.8 HERA BIOLABS

12.8.1 COMPANY OVERVIEW
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS

12.9 HORIZON DISCOVERY GROUP PLC

12.9.1 COMPANY OVERVIEW
12.9.2 REVENUE ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS

12.10 MI BIORESEARCH INC

12.10.1 COMPANY OVERVIEW
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENTS

12.11 ONCODESIGN

12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS

12.12 PHARMATEST SERVICES LTD

12.12.1 COMPANY OVERVIEW
12.12.2 GEOGRAPHIC PRESENCE
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS

12.13 THE JACKSON LABORATORY

12.13.1 COMPANY OVERVIEW
12.13.2 REVENUE ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS

12.14 UROLEAD

12.14.1 COMPANY OVERVIEW
12.14.2 PRODUCT PORTFOLIO
12.14.3 RECENT DEVELOPMENTS

12.15 WUXI APPTEC

12.15.1 COMPANY OVERVIEW
12.15.2 GEOGRAPHIC PRESENCE
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS

12.16 XENTECH

12.16.1 COMPANY OVERVIEW
12.16.2 PRODUCT PORTFOLIO
12.16.3 RECENT DEVELOPMENTS

13 RELATED REPORTS

LIST OF TABLES GLOBAL PDX MODELS MARKET

TABLE 1 GLOBAL PDX MODELS MARKET, BY TYPE, 2016– 2025, (USD MILLION)

TABLE 2 GLOBAL MICE MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 3 GLOBAL RAT MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 4 GLOBAL PDX MODELS MARKET, BY TUMOR TYPE, 2016– 2025 (USD MILLION)

TABLE 5 GLOBAL GASTROINTESTINAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 6 GLOBAL GYNECOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 7 GLOBAL RESPIRATORY TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 8 GLOBAL UROLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 9 GLOBAL HEMATOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 10 GLOBAL OTHERS TUMOR TYPES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 11 GLOBAL PDX MODELS MARKET, BY APPLICATION, 2016– 2025 (USD MILLION)

TABLE 12 GLOBAL PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 13 GLOBAL BIOMARKER ANALYSIS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 14 GLOBAL PDX MODELS MARKET, BY END USER, 2016– 2025, (USD MILLION)

TABLE 15 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN PDX MODEL MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 16 GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 17 GLOBAL ACADEMIC AND RESEARCH INSTITUTIONS IN PDX MODELA MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 18 GLOBAL PDX MODELS MARKET, BY GEOGRAPHY, 2016 – 2025, (USD MILLION)

TABLE 19 NORTH AMERICA PDX MODELS MARKET, BY COUNTRY, 2016 – 2025, (USD MILLION)

TABLE 20 NORTH AMERICA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 21 NORTH AMERICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 22 NORTH AMERICA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 23 NORTH AMERICA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 24 U.S. PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 25 U.S. PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 26 U.S. PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 27 U.S. PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 28 CANADA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 29 CANADA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 30 CANADA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 31 CANADA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 32 MEXICO PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 33 MEXICO PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 34 MEXICO PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 35 MEXICO PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 36 EUROPE PDX MODELS MARKET, BY COUNTRY , 2016 – 2025 (USD MILLION)

TABLE 37 EUROPE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 38 EUROPE PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 39 EUROPE PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 40 EUROPE PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 41 GERMANY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 42 GERMANY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 43 GERMANY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 44 GERMANY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 45 FRANCE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 46 FRANCE PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 47 FRANCE PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 48 FRANCE PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 49 U.K. PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 50 U.K. PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 51 U.K. PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 52 U.K. PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 53 ITALY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 54 ITALY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 55 ITALY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 56 ITALY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 57 SPAIN PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 58 SPAIN PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 59 SPAIN PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 60 SPAIN PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 61 SWITZERLAND PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 62 SWITZERLAND PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 63 SWITZERLAND PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 64 SWITZERLAND PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 65 NETHERLANDS PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 66 NETHERLANDS PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 67 NETHERLANDS PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 68 NETHERLANDS PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 69 TURKEY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 70 TURKEY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 71 TURKEY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 72 TURKEY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 73 BELGIUM PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 74 BELGIUM PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 75 BELGIUM PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 76 BELGIUM PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 77 RUSSIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 78 RUSSIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 79 RUSSIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 80 RUSSIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 81 REST OF EUROPE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 82 ASIA PACIFIC PDX MODELS MARKET, BY COUNTRY , 2016 – 2025, (USD MILLION)

TABLE 83 ASIA PACIFIC PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 84 ASIA PACIFIC PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 85 ASIA PACIFIC PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 86 ASIA PACIFIC PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 87 JAPAN PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 88 JAPAN PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 89 JAPAN PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 90 JAPAN PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 91 CHINA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 92 CHINA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 93 CHINA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 94 CHINA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 95 INDIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 96 INDIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 97 INDIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 98 INDIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 99 SOUTH KOREA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 100 SOUTH KOREA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 101 SOUTH KOREA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 102 SOUTH KOREA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 103 AUSTRALIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 104 AUSTRALIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 105 AUSTRALIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 106 AUSTRALIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 107 SINGAPORE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 108 SINGAPORE PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 109 SINGAPORE PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 110 SINGAPORE PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 111 THAILAND PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 112 THAILAND PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 113 THAILAND PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 114 THAILAND PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 115 MALAYSIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 116 MALAYSIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 117 MALAYSIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 118 MALAYSIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 119 INDONESIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 120 INDONESIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 121 INDONESIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 122 INDONESIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 123 PHILIPPINES PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 124 PHILIPPINES PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 125 PHILIPPINES PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 126 PHILIPPINES PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 127 REST OF ASIA PACIFIC PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 128 SOUTH AMERICA PDX MODELS MARKET, BY COUNTRY, 2016-2025, (USD MILLION)

TABLE 129 SOUTH AMERICA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 130 SOUTH AMERICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 131 SOUTH AMERICA IN PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 132 SOUTH AMERICA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 133 BRAZIL PDX MODELS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 134 BRAZIL PDX MODEL MARKET, BY TUMOR TYPE, 2016 – 2025 (USD MILLION)

TABLE 135 BRAZIL PDX MODELS MARKET, BY APPLICATION , 2016 - 2025 (USD MILLION)

TABLE 136 BRAZIL PDX MODEL MARKET, BY END USER, 2016 - 2025 (USD MILLION)

TABLE 137 REST OF SOUTH AMERICA PDX MODELS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 138 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY COUNTRY, 2016-2025, (USD MILLION)

TABLE 139 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 140 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 141 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 142 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 143 SOUTH AFRICA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 144 SOUTH AFRICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 145 SOUTH AFRICA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 146 SOUTH AFRICA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 147 REST OF MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY TYPE, 2016-2025, (USD MILLION)

LIST OF FIGURES GLOBAL PDX MODELS MARKET

FIGURE 1 GLOBAL PDX MODELS MARKET: SEGMENTATION

FIGURE 2 GLOBAL PDX MODELS MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL PDX MODELS MARKET: RESEARCH SNAPSHOT

FIGURE 4 GLOBAL PDX MODELS MARKET : BOTTOM UP APPROACH

FIGURE 5 GLOBAL PDX MODELS MARKET : TOP DOWN APPROACH

FIGURE 6 GLOBAL PDX MODELS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF PDX MODELS MARKET

FIGURE 8 BELOW MENTIONED IS R&D EXPENSE BY THE JACKSON LABORATORY FOR YEAR 2016-17

FIGURE 9 GLOBAL PDX MODELS MARKET: SEGMENTATION

FIGURE 10 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE PDX MODELS MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025

FIGURE 11 RISING NUMBER OF PHARMACEUTICAL R&D ACTIVITIES IN CANCER RESEARCH AND RISING NEED FOR PERSONALIZED MEDICINE ARE EXPECTED TO DRIVE THE MARKET FOR PDX MODELS IN THE FORECAST PERIOD 2018 TO 2025

FIGURE 12 MICE MODELS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PDX MODELS MARKET IN 2018 & 2025

FIGURE 13 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR PDX MODELS MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025

FIGURE 14 GLOBAL PDX MODELS MARKET: BY TYPE, 2017

FIGURE 15 GLOBAL PDX MODELS MARKET: BY TYUMOR TYPE, 2017

FIGURE 16 GLOBAL PDX MODELS MARKET: BY APPLICATION, 2017

FIGURE 17 GLOBAL PDX MODELS MARKET: BY END USER, 2017

FIGURE 18 GLOBAL PDX MODELS MARKET: SNAPSHOT (2017)

FIGURE 19 GLOBAL PDX MODELS MARKET: BY GEOGRAPHY (2017)

FIGURE 20 GLOBAL PDX MODELS MARKET: BY GEOGRAPHY (2018 & 2025)

FIGURE 21 GLOBAL PDX MODELS MARKET, BY GEOGRAPHY (2017 & 2025)

FIGURE 22 GLOBAL PDX MODELS MARKET, BY TYPE (2018 - 2025)

FIGURE 23 NORTH AMERICA PDX MODELS MARKET SNAPSHOT (2017)

FIGURE 24 NORTH AMERICA PDX MODELS MARKET: BY COUNTRY (2017)

FIGURE 25 NORTH AMERICA PDX MODELS MARKET: BY COUNTRY (2018 & 2025)

FIGURE 26 NORTH AMERICA PDX MODELS MARKET: BY COUNTRY (2017 & 2025)

FIGURE 27 NORTH AMERICA PDX MODELS MARKET, BY TYPE (2018 - 2025)

FIGURE 28 EUROPE PDX MODELS MARKET SNAPSHOT (2017)

FIGURE 29 EUROPE PDX MODELS MARKET: BY COUNTRY (2017)

FIGURE 30 EUROPE PDX MODELS MARKET: BY COUNTRY (2018 & 2025)

FIGURE 31 EUROPE PDX MODELS MARKET: BY COUNTRY (2017 & 2025)

FIGURE 32 EUROPE PDX MODELS MARKET: BY TYPE (2018-2025)

FIGURE 33 ASIA PACIFIC PDX MODELS MARKET SNAPSHOT (2017)

FIGURE 34 ASIA PACIFIC PDX MODELS MARKET : BY COUNTRY (2017)

FIGURE 35 ASIA PACIFIC PDX MODELS MARKET : BY COUNTRY (2018 & 2025)

FIGURE 36 ASIA PACIFIC PDX MODELS MARKET: BY COUNTRY (2017 & 2025)

FIGURE 37 ASIA PACIFIC PDX MODELS MARKET : BY TYPE (2018-2025)

FIGURE 38 SOUTH AMERICA PDX MODELS MARKET SNAPSHOT (2017)

FIGURE 39 SOUTH AMERICA PDX MODELS MARKET: BY COUNTRY (2017)

FIGURE 40 SOUTH AMERICA PDX MODELS MARKET: BY COUNTRY (2018 & 2025)

FIGURE 41 SOUTH AMERICA PDX MODELS MARKET: BY COUNTRY (2017 & 2025)

FIGURE 42 SOUTH AMERICA PDX MODELS MARKET, BY TYPE (2018 - 2025)

FIGURE 43 MIDDLE EAST AND AFRICA PDX MODELS MARKET SNAPSHOT (2017)

FIGURE 44 MIDDLE EAST AND AFRICA PDX MODELS MARKET: BY COUNTRY (2017)

FIGURE 45 MIDDLE EAST AND AFRICA PDX MODELS MARKET: BY COUNTRY (2018 & 2025)

FIGURE 46 MIDDLE EAST AND AFRICA PDX MODELS MARKET: BY COUNTRY (2017 & 2025)

FIGURE 47 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY TYPE (2018 - 2025)

FIGURE 48 GLOBAL PDX MODELS MARKET: COMPANY SHARE 2017 (%)

FIGURE 49 NORTH AMERICA PDX MODELS MARKET: COMPANY SHARE 2017(%)

FIGURE 50 EUROPE PDX MODELS MARKET: COMPANY SHARE 2017 (%)

FIGURE 51 ASIA-PACIFIC PDX MODELS MARKET: COMPANY SHARE 2017 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART